Business Wire

Rapyd’s 2026 State of Stablecoins: Businesses Move En Masse as Stablecoins Go Mainstream

14.1.2026 14:00:00 CET | Business Wire | Press Release

Share

Rapyd, a leading global fintech company, released its 2026 State of Stablecoins Report, revealing that stablecoins have reached a tipping point and are becoming a foundational component of global commerce rather than a niche digital asset.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114427729/en/

Rapyd research shows 64% of businesses already use stablecoins or plan to within three years, as speed, cross-border efficiency, and cost savings drive mainstream adoption.

The report shows the market has moved decisively into active, real-world use. Today, nearly one in five businesses already consider stablecoins a mainstream financial tool. Looking ahead, a much larger majority (76%) believe stablecoins are either already mainstream or will become mainstream within the next five years.

This shift in perception is translating into action: 64% of businesses surveyed either use stablecoins today or plan to adopt them within the next three years, signaling a move from crypto curiosity to institutional-grade execution.

The findings, drawing on a global survey of business decision-makers across multiple industries in APAC, the Americas, and EMEA, highlight how stablecoins are increasingly used to improve operational speed, reduce costs, and simplify cross-border payments and treasury operations.

Key findings from the State of Stablecoins Report include:

  • Mainstream momentum is accelerating: Stablecoin utilization among businesses has reached 34%, with a strong adoption pipeline with 48% of organizations planning to adopt stablecoins within the next 12 months.
  • Cross-border commerce is the primary use case: 72% of businesses rank faster payments and settlements as a key benefit, while 62% cite easier cross-border transactions.
  • Stablecoins are delivering measurable financial impact: 60% of organizations report cost savings as a primary benefit, demonstrating that stablecoins are now a profitability driver rather than a technology experiment.
  • Trust is high, but regulation remains the main concern: Over 83% of businesses rate their trust in stablecoins as moderate to high, while regulatory uncertainty remains the top barrier to adoption.
  • Smaller businesses are leading the way: Companies with 51–100 employees show the highest current usage at 50%, while larger enterprises remain more cautious.

Treasury moves to the center of stablecoin adoption

The report points to a shift in how businesses approach treasury operations. Based on Rapyd’s research findings, faster settlements and cross-border payments consistently emerge as the primary drivers of stablecoin adoption, underscoring the importance of speed and efficiency in global money movement. From Rapyd’s perspective, stablecoins play a growing role in enabling funds to move more quickly across entities and geographies, helping businesses operate with greater flexibility and less friction.

Taken together, these findings highlight a broader move from experimentation toward execution in how businesses approach global payments and treasury infrastructure.

“Stablecoins have crossed a threshold where the conversation is no longer about potential, but about execution,” said Arik Shtilman, CEO and Co-Founder of Rapyd. “Our research shows businesses are using stablecoins to move money faster, lower costs, and operate more efficiently internationally. This is not about speculation. It is about building modern financial infrastructure that works at global scale.”

For CFOs and corporate treasuries, the report underscores a clear shift in perception. Stablecoins are no longer viewed as alternative assets, but as liquidity tools. Businesses are using stablecoins to accelerate payments, reduce FX and banking fees, and enable just-in-time funding across regions to free up capital.

“Treasury teams are under increasing pressure to manage liquidity in real time across multiple markets,” said Kristin Reischel, Senior Director of Solutions and Partner Marketing at Rapyd. “What we are seeing in this research is a practical shift. Stablecoins allow businesses to deploy capital globally without the friction of traditional banking structures. That flexibility is becoming essential for companies operating across borders.”

While regulatory uncertainty remains the leading concern for businesses exploring stablecoins, the report finds that trust in the technology itself is already well established. This gap between confidence and adoption highlights the importance of compliant infrastructure and operational expertise to support enterprise use at scale.

Rapyd’s 2026 State of Stablecoins Report is available now and provides a detailed analysis of adoption trends, use cases, and implications for global payments and treasury operations.

Download the full report here.

About Rapyd

Rapyd lets you build bold. Liberate global commerce with all the tools your business needs to create payment, payout and fintech experiences everywhere. From Fortune 500s to ambitious business and technology upstarts, our payments network and powerful fintech platform make it easy to pay suppliers and get paid by customers—locally or internationally.

With offices worldwide, including London, Tel Aviv, Dubai, Iceland, Amsterdam, Miami, Hong Kong and Singapore, we know what it takes to make cross-border commerce as easy as being next door. Rapyd simplifies payments so you can focus on building your business.

Get the tools to grow globally and learn about our products, solutions and partner programmes at www.rapyd.net. Follow: Blog, Insta, LinkedIn, Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114427729/en/

Contacts

Media Contact: press@rapyd.net

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release

Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye